Low Intensity Vibration for Breast Cancer Survivor Muscle Function
Trial Summary
What is the purpose of this trial?
This trial tests if gentle body vibrations can help improve muscle and bone health in early-stage breast cancer patients who are starting a specific therapy and don't exercise regularly. The vibrations are done for short periods each day.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify if you need to stop your current medications. However, if you are taking bisphosphonates or denosumab, you must not have used them in the past 12 months. Also, if you are switching from tamoxifen to an aromatase inhibitor, there must be a 28-day gap between the last tamoxifen dose and the start of the trial.
What data supports the idea that Low Intensity Vibration for Breast Cancer Survivor Muscle Function is an effective treatment?
The available research shows that Low Intensity Vibration (LIV) does not significantly improve muscle activity or perceived exertion in breast cancer survivors compared to healthy controls. In a study where participants performed exercises on a vibration platform, there were no significant differences in muscle activity or how hard the exercise felt between the two groups. This suggests that LIV might not be more effective than other treatments for improving muscle function in breast cancer survivors.12345
What safety data exists for Low Intensity Vibration treatment?
The study titled 'Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand' provides relevant safety data. It reports that vibration therapy was well-tolerated with only occasional mild itchiness, indicating it is safe. The study supports further exploration of vibration therapy's potential health benefits.678910
Is the treatment Macrodyne LivMD plate a promising treatment for improving muscle function in breast cancer survivors?
Yes, the Macrodyne LivMD plate, which uses low intensity vibration, is a promising treatment. Research shows that vibration therapy can improve muscle strength and performance by activating more muscle fibers, which can be beneficial for breast cancer survivors looking to enhance their muscle function.27111213
Research Team
Tarah Ballinger, MD
Principal Investigator
Indiana University
Eligibility Criteria
This trial is for early stage breast cancer survivors who are about to start aromatase inhibitor therapy and don't regularly exercise. Participants should be post-menopausal or premenopausal with ovarian suppression, have a good performance status, weigh less than 275 lbs., able to stand unassisted for 10 minutes, and completed primary cancer treatments. Exclusions include severe heart conditions, muscle disorders, metastatic breast cancer, certain bone diseases, chronic renal disease or planned cochlear implant.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Macrodyne LivMD plate (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Alan Palkowitz
Indiana University
Chief Executive Officer since 2020
PhD in Chemistry from Indiana University
David Ingram
Indiana University
Chief Medical Officer since 2020
MD from Indiana University School of Medicine